Cargando…
Roles of RAGE/ROCK1 Pathway in HMGB1-Induced Early Changes in Barrier Permeability of Human Pulmonary Microvascular Endothelial Cell
BACKGROUND: High mobility group box 1 (HMGB1) causes microvascular endothelial cell barrier dysfunction during acute lung injury (ALI) in sepsis, but the mechanisms have not been well understood. We studied the roles of RAGE and Rho kinase 1 (ROCK1) in HMGB1-induced human pulmonary endothelial barri...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564108/ https://www.ncbi.nlm.nih.gov/pubmed/34745088 http://dx.doi.org/10.3389/fimmu.2021.697071 |
_version_ | 1784593545448914944 |
---|---|
author | Zhao, Meng-jiao Jiang, Hao-ran Sun, Jing-wen Wang, Zi-ang Hu, Bo Zhu, Cheng-rui Yin, Xiao-han Chen, Ming-ming Ma, Xiao-chun Zhao, Wei-dong Luan, Zheng-gang |
author_facet | Zhao, Meng-jiao Jiang, Hao-ran Sun, Jing-wen Wang, Zi-ang Hu, Bo Zhu, Cheng-rui Yin, Xiao-han Chen, Ming-ming Ma, Xiao-chun Zhao, Wei-dong Luan, Zheng-gang |
author_sort | Zhao, Meng-jiao |
collection | PubMed |
description | BACKGROUND: High mobility group box 1 (HMGB1) causes microvascular endothelial cell barrier dysfunction during acute lung injury (ALI) in sepsis, but the mechanisms have not been well understood. We studied the roles of RAGE and Rho kinase 1 (ROCK1) in HMGB1-induced human pulmonary endothelial barrier disruption. METHODS: In the present study, the recombinant human high mobility group box 1 (rhHMGB1) was used to stimulate human pulmonary microvascular endothelial cells (HPMECs). The endothelial cell (EC) barrier permeability was examined by detecting FITC-dextran flux. CCK-8 assay was used to detect cell viability under rhHMGB1 treatments. The expression of related molecules involved in RhoA/ROCK1 pathway, phosphorylation of myosin light chain (MLC), F-actin, VE-cadherin and ZO-1 of different treated groups were measured by pull-down assay, western blot and immunofluorescence. Furthermore, we studied the effects of Rho kinase inhibitor (Y-27632), ROCK1/2 siRNA, RAGE-specific blocker (FPS-ZM1) and RAGE siRNA on endothelial barrier properties to elucidate the related mechanisms. RESULTS: In the present study, we demonstrated that rhHMGB1 induced EC barrier hyperpermeability in a dose-dependent and time-dependent manner by measuring FITC-dextran flux, a reflection of the loss of EC barrier integrity. Moreover, rhHMGB1 induced a dose-dependent and time-dependent increases in paracellular gap formation accompanied by the development of stress fiber rearrangement and disruption of VE-cadherin and ZO-1, a phenotypic change related to increased endothelial contractility and endothelial barrier permeability. Using inhibitors and siRNAs directed against RAGE and ROCK1/2, we systematically determined that RAGE mediated the rhHMGB1-induced stress fiber reorganization via RhoA/ROCK1 signaling activation and the subsequent MLC phosphorylation in ECs. CONCLUSION: HMGB1 is capable of disrupting the endothelial barrier integrity. This study demonstrates that HMGB1 activates RhoA/ROCK1 pathway via RAGE, which phosphorylates MLC inducing stress fiber formation at short time, and HMGB1/RAGE reduces AJ/TJ expression at long term independently of RhoA/ROCK1 signaling pathway. |
format | Online Article Text |
id | pubmed-8564108 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85641082021-11-04 Roles of RAGE/ROCK1 Pathway in HMGB1-Induced Early Changes in Barrier Permeability of Human Pulmonary Microvascular Endothelial Cell Zhao, Meng-jiao Jiang, Hao-ran Sun, Jing-wen Wang, Zi-ang Hu, Bo Zhu, Cheng-rui Yin, Xiao-han Chen, Ming-ming Ma, Xiao-chun Zhao, Wei-dong Luan, Zheng-gang Front Immunol Immunology BACKGROUND: High mobility group box 1 (HMGB1) causes microvascular endothelial cell barrier dysfunction during acute lung injury (ALI) in sepsis, but the mechanisms have not been well understood. We studied the roles of RAGE and Rho kinase 1 (ROCK1) in HMGB1-induced human pulmonary endothelial barrier disruption. METHODS: In the present study, the recombinant human high mobility group box 1 (rhHMGB1) was used to stimulate human pulmonary microvascular endothelial cells (HPMECs). The endothelial cell (EC) barrier permeability was examined by detecting FITC-dextran flux. CCK-8 assay was used to detect cell viability under rhHMGB1 treatments. The expression of related molecules involved in RhoA/ROCK1 pathway, phosphorylation of myosin light chain (MLC), F-actin, VE-cadherin and ZO-1 of different treated groups were measured by pull-down assay, western blot and immunofluorescence. Furthermore, we studied the effects of Rho kinase inhibitor (Y-27632), ROCK1/2 siRNA, RAGE-specific blocker (FPS-ZM1) and RAGE siRNA on endothelial barrier properties to elucidate the related mechanisms. RESULTS: In the present study, we demonstrated that rhHMGB1 induced EC barrier hyperpermeability in a dose-dependent and time-dependent manner by measuring FITC-dextran flux, a reflection of the loss of EC barrier integrity. Moreover, rhHMGB1 induced a dose-dependent and time-dependent increases in paracellular gap formation accompanied by the development of stress fiber rearrangement and disruption of VE-cadherin and ZO-1, a phenotypic change related to increased endothelial contractility and endothelial barrier permeability. Using inhibitors and siRNAs directed against RAGE and ROCK1/2, we systematically determined that RAGE mediated the rhHMGB1-induced stress fiber reorganization via RhoA/ROCK1 signaling activation and the subsequent MLC phosphorylation in ECs. CONCLUSION: HMGB1 is capable of disrupting the endothelial barrier integrity. This study demonstrates that HMGB1 activates RhoA/ROCK1 pathway via RAGE, which phosphorylates MLC inducing stress fiber formation at short time, and HMGB1/RAGE reduces AJ/TJ expression at long term independently of RhoA/ROCK1 signaling pathway. Frontiers Media S.A. 2021-10-20 /pmc/articles/PMC8564108/ /pubmed/34745088 http://dx.doi.org/10.3389/fimmu.2021.697071 Text en Copyright © 2021 Zhao, Jiang, Sun, Wang, Hu, Zhu, Yin, Chen, Ma, Zhao and Luan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Zhao, Meng-jiao Jiang, Hao-ran Sun, Jing-wen Wang, Zi-ang Hu, Bo Zhu, Cheng-rui Yin, Xiao-han Chen, Ming-ming Ma, Xiao-chun Zhao, Wei-dong Luan, Zheng-gang Roles of RAGE/ROCK1 Pathway in HMGB1-Induced Early Changes in Barrier Permeability of Human Pulmonary Microvascular Endothelial Cell |
title | Roles of RAGE/ROCK1 Pathway in HMGB1-Induced Early Changes in Barrier Permeability of Human Pulmonary Microvascular Endothelial Cell |
title_full | Roles of RAGE/ROCK1 Pathway in HMGB1-Induced Early Changes in Barrier Permeability of Human Pulmonary Microvascular Endothelial Cell |
title_fullStr | Roles of RAGE/ROCK1 Pathway in HMGB1-Induced Early Changes in Barrier Permeability of Human Pulmonary Microvascular Endothelial Cell |
title_full_unstemmed | Roles of RAGE/ROCK1 Pathway in HMGB1-Induced Early Changes in Barrier Permeability of Human Pulmonary Microvascular Endothelial Cell |
title_short | Roles of RAGE/ROCK1 Pathway in HMGB1-Induced Early Changes in Barrier Permeability of Human Pulmonary Microvascular Endothelial Cell |
title_sort | roles of rage/rock1 pathway in hmgb1-induced early changes in barrier permeability of human pulmonary microvascular endothelial cell |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564108/ https://www.ncbi.nlm.nih.gov/pubmed/34745088 http://dx.doi.org/10.3389/fimmu.2021.697071 |
work_keys_str_mv | AT zhaomengjiao rolesofragerock1pathwayinhmgb1inducedearlychangesinbarrierpermeabilityofhumanpulmonarymicrovascularendothelialcell AT jianghaoran rolesofragerock1pathwayinhmgb1inducedearlychangesinbarrierpermeabilityofhumanpulmonarymicrovascularendothelialcell AT sunjingwen rolesofragerock1pathwayinhmgb1inducedearlychangesinbarrierpermeabilityofhumanpulmonarymicrovascularendothelialcell AT wangziang rolesofragerock1pathwayinhmgb1inducedearlychangesinbarrierpermeabilityofhumanpulmonarymicrovascularendothelialcell AT hubo rolesofragerock1pathwayinhmgb1inducedearlychangesinbarrierpermeabilityofhumanpulmonarymicrovascularendothelialcell AT zhuchengrui rolesofragerock1pathwayinhmgb1inducedearlychangesinbarrierpermeabilityofhumanpulmonarymicrovascularendothelialcell AT yinxiaohan rolesofragerock1pathwayinhmgb1inducedearlychangesinbarrierpermeabilityofhumanpulmonarymicrovascularendothelialcell AT chenmingming rolesofragerock1pathwayinhmgb1inducedearlychangesinbarrierpermeabilityofhumanpulmonarymicrovascularendothelialcell AT maxiaochun rolesofragerock1pathwayinhmgb1inducedearlychangesinbarrierpermeabilityofhumanpulmonarymicrovascularendothelialcell AT zhaoweidong rolesofragerock1pathwayinhmgb1inducedearlychangesinbarrierpermeabilityofhumanpulmonarymicrovascularendothelialcell AT luanzhenggang rolesofragerock1pathwayinhmgb1inducedearlychangesinbarrierpermeabilityofhumanpulmonarymicrovascularendothelialcell |